4
Changes in Ownership
Minerva Neurosciences, Inc. Filed Acc 0001209191-17-065970
CEO sold 2,194 shares at $5.85 ($12,835)
- CEO acquired 18,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luthringer Remy CEO | 2017-12-14 | Option exercise | +18,750 | 18,750 | D: show line 1 in the form | ||
| Luthringer Remy CEO | 2017-12-14 | Sale | −2,194 | $5.85 | $12,835 | 16,556 | D: show line 2 in the form |
| Open-market sales · 2,194 sh · avg $5.85 · $12,835 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luthringer Remy CEO | 2017-12-13 | Grant or award · Employee Stock Option (Right to Buy) | +350,000 | 350,000 | D: show line 3 in the form | ||
| Luthringer Remy CEO | 2017-12-14 | Option exercise · Restricted Stock Unit | −18,750 | 56,250 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…